Several studies found that Fbxo4 expression is downregulated in hepatocellular carcinoma (HCC) and HNSCC tissues comparing to their normal counterparts, and Fbxo4 loss of function mutations are revealed in human ESCC tissues and melanoma cells [1,21,33,79]. This evidence concerns the gene FBXO4 and melanoma.